Page 1 | Search Results | Blood | American Society of Hematology

1-14 of 14

Sort by

Sort Order Select

Journal Articles

Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data

Isabelle Mahe, Céline Chapelle, Luis Jara-Palomares, Olivier Sanchez, Philippe Girard, Guy Meyer, Agnes Yuet Ying Lee, Géraldine Poénou, Silvy Laporte

Blood (2023) 142 (Supplement 1): 2646.

https://doi.org/10.1182/blood-2023-177979

Published: 2023

Journal Articles

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Isabelle Mahe, MD PhD, Jean Chidiac, MD, Sadji Djennaoui, MD, Nicolas Javaud, MD PhD, Benjamin Planquette, MD PhD, Edith Peynaud-Debayle, MD, Laurent Sofiane Baccar, MD, Bénédicte Dumont, PhD, Guy Meyer, Geneviève Contant, PhD, Francois Depasse, PharmD, Virginie Siguret, PhD, Hélène Helfer, PhD

Blood (2019) 134 (Supplement_1): 3663.

https://doi.org/10.1182/blood-2019-124973

Published: 2019

Journal Articles

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Isabelle Mahe, MD PhD, Ludovic Plaisance, MD, Céline Chapelle, Silvy Laporte, MS, PhD, Benjamin Planquette, MD PhD, Laurent Bertoletti, MD PhD, Jean Chidiac, MD, Francis Couturaud, MD PhD, Lionel Falchiero, MD, Nicolas Falvo, MD, Isild Mahé, Hélène Helfer, PhD, Guy Meyer

Blood (2019) 134 (Supplement_1): 3664.

https://doi.org/10.1182/blood-2019-124745

Published: 2019

Journal Articles

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Guy Meyer, Celine Chapelle, Philippe Girard, MD, Florian Scotté, MD PhD, Anne Lamblin, Silvy Laporte, MS, PhD

Blood (2019) 134 (Supplement_1): 167.

https://doi.org/10.1182/blood-2019-129087

Published: 2019

Journal Articles

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)

Hervé Decousus, Aurélie Bourmaud, Pierre Fournel, Laurent Bertoletti, Carine Labruyère, Emilie Presles, Adel Merah, Silvy Laporte, Laetitia Stefani, Francesco Del Piano, Jean-Philippe Jacquin, Guy Meyer, Franck Chauvin

Blood (2018) 132 (7): 707–716.

https://doi.org/10.1182/blood-2018-03-837153

Published: 2018

Includes: Supplemental data

Journal Articles

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Gary E. Raskob, PhD, Nick Van Es, MD, Peter Verhamme, MD PhD, Marc Carrier, MD, Marcello Di Nisio, MD, David A. Garcia, MD, Michael A. Grosso, MD, Ajay K. Kakkar, MBBS, Michael J. Kovacs, MD, Michele F. Mercuri, MD PhD FAHA, Guy Meyer, MD, Annelise Segers, MD, Minggao Shi, PhD, Tzu-Fei Wang, MD, Erik Yeo, MD FACP, FRCPC, George Zhang, PhD, Jeffrey I. Zwicker, MD, Jeffrey I. Weitz, MD, Harry R. Büller, MD PhD

Blood (2017) 130 (Supplement 1): LBA-6.

https://doi.org/10.1182/blood.V130.Suppl_1.LBA-6.LBA-6

Published: 2017

Journal Articles

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Davendra P. S. Sohal, MD MPH, Nicole M. Kuderer, MD, Frances A. Shepherd, MD FRCPC, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Gary H. Lyman, MD MPH, Alok A. Khorana, MD

Blood (2016) 128 (22): 1422.

https://doi.org/10.1182/blood.V128.22.1422.1422

Published: 2016

Journal Articles

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

Nicole M. Kuderer, MD, Marek S. Poniewierski, MD MS, MS, Eva Culakova, PhD MS, Gary H. Lyman, MD MPH, Alok A. Khorana, MD, Ingrid Pabinger, Prof, Giancarlo Agnelli, MD, Howard A. Liebman, MA, MD, Eric Vicaut, MD, Guy Meyer, MD, Frances A. Shepherd, MD FRCPC

Blood (2016) 128 (22): 3590.

https://doi.org/10.1182/blood.V128.22.3590.3590

Published: 2016

Journal Articles

The Impacts of Thromboembolic Events in Breast and Prostate Cancer Patients: Incidence, Hospitalization Duration and Costs

Isabelle Borget, PharmD, PhD, Guy Meyer, MD PhD, Alexandre Vainchtock, PharmD, PhD, Nicolas Martelli, PharmD, PhD, Florian Scotté, MD PhD, Ismail Elalamy, MDPhD

Blood (2014) 124 (21): 4828.

https://doi.org/10.1182/blood.V124.21.4828.4828

Published: 2014

Journal Articles

The Cost of Hospitalization for Thromboembolic Events in Patients with Colon or Lung Cancer

Isabelle Borget, PharmD, PhD, Guy Meyer, MD PhD, Florian Scotté, MD PhD, Nicolas Martelli, PharmD, PhD, Alexandre Vainchtock, PharmD, PhD, Ismail Elalamy, MDPhD

Blood (2014) 124 (21): 3515.

https://doi.org/10.1182/blood.V124.21.3515.3515

Published: 2014

Journal Articles

A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study

Agnes Y.Y. Lee, MD, Pieter W. Kamphuisen, MD PhD, Guy Meyer, MD, Rupert Bauersachs, MD, Mette S. Janas, MD PhD, Mikala F Jarner, MSc, Alok A. Khorana, MD on behalf of the CATCH Investigators

Blood (2014) 124 (21): LBA-2.

https://doi.org/10.1182/blood.V124.21.LBA-2.LBA-2

Published: 2014

Journal Articles

Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

Blood (2014) 124 (21): LBA-3.

https://doi.org/10.1182/blood.V124.21.LBA-3.LBA-3

Published: 2014

Journal Articles

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

Martha L Louzada, BSc, MD, Marc Carrier, MD, MSc, Alejandro Lazo-Langner, MD, MSC, Vi Dao, MD, Jerry Zhang, MD, Michael J. Kovacs, MD, FRCPC, Agnes Y. Lee, MD, MSc, Mark N. Levine, MD, MSC, Guy Meyer, MD, Marc Rodger, Philip Wells, MD, FRCPC, MSc

Blood (2010) 116 (21): 4209.

https://doi.org/10.1182/blood.V116.21.4209.4209

Published: 2010

Journal Articles

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Blood (2008) 112 (11): 1284.

https://doi.org/10.1182/blood.V112.11.1284.1284

Published: 2008

NARROW

Efficacy and Safety Outcomes in Patients with Cancer-Associated Thromboembolism Treated with Tinzaparin According to the Tumor Site: Meta-Analysis of Prospective Studies Involving 1413 Individual Patients' Data

Evaluation of the Fibrin Assay for Venous Thromboembolism Exclusion in Cancer Patients: Subanalysis of a Prospective Assessment (FSET STUDY)

Use of Anticoagulants of Patients with Cancer-Associated Thrombosis Beyond 6 Months ; The Uscat Study, a 432-Patient Retrospective Non-Interventional Study

Validation of the Ottawa Score in Cancer Patients with Venous Thromboembolism. the Predicare Cohort Study

Cancer-associated thrombosis in patients with implanted ports: a prospective multicenter French cohort study (ONCOCIP)

A Randomized, Open-Label, Blinded Outcome Assessment Trial Evaluating the Efficacy and Safety of LMWH/Edoxaban Versus Dalteparin for Venous Thromboembolism Associated with Cancer: Hokusai VTE-Cancer Study

Predictors of Venous Thmromboembolism in Colorectal Cancer: Results from a Global Prospective Study

Global Prospective Cohort Study of Factors Associated with Venous Thromboembolism in Patients with Lung Cancer Receiving Cancer Therapy

The Impacts of Thromboembolic Events in Breast and Prostate Cancer Patients: Incidence, Hospitalization Duration and Costs

The Cost of Hospitalization for Thromboembolic Events in Patients with Colon or Lung Cancer

A Randomized Trial of Long-Term Tinzaparin, a Low Molecular Weight Heparin (LMWH), Versus Warfarin for Treatment of Acute Venous Thromboembolism (VTE) in Cancer Patients - the CATCH Study

Two Years Versus Six Months of Oral Anticoagulation after a First Episode of Unprovoked Pulmonary Embolism: The Padis PE Multicenter, Double-Blind, Randomized Trial

Validation of A Clinical Prediction Rule for Risk Stratification of Recurrent Venous Thromboembolism In Patients with Cancer-Associated Venous Thromboembolism

2008 Guidelines for the Treatment of Venous Thromboembolism in Cancer Patients: Report from the French Working Group.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only